Researchers analyzed data from over 5,000 thyroid nodules to see how different imaging techniques perform. They specifically looked at how contrast-enhanced ultrasound (CEUS) works when combined with other methods like ultrasound elastography (UE), artificial intelligence (AI), and conventional ultrasound (US). The goal was to see how well these combinations could tell the difference between benign and malignant nodules.
The study found that combining CEUS with ultrasound elastography showed favorable results for overall diagnosis. When CEUS was paired with artificial intelligence, it showed potential for identifying high-risk nodules. Additionally, combining CEUS with conventional ultrasound was found to be effective for identifying nodules that do not require specific risk stratification.
Because this was a network meta-analysis, the results are based on existing data rather than a new clinical trial. The findings are promising but need more validation in larger, diverse groups of patients before they can change standard medical practice. Patients should discuss these imaging options with their doctors to determine the best approach for their specific situation.
